16.92 USD
↗ 0.65 (4.00%)AT CLOSE (11:59 AM EDT)
Amylyx Pharmaceuticals, Inc. Common Stock
AMLXNASDAQ • USD
16.94
↗ 0.02 (0.12%)
POST MARKET (AS OF 07:21 PM EDT)
Post Market
AS OF 07:21 PM EDT
16.94
↗ 0.02 (0.12%)
Market: OPEN
Open?$16.76
High?$17.06
Low?$16.26
Prev. Close?$16.27
Volume?1.5M
Avg. Volume?1.1M
VWAP?$16.79
Rel. Volume?1.36x
Bid / Ask
Bid?$14.25 × 100
Ask?$19.20 × 100
Spread?$4.95
Midpoint?$16.73
Valuation & Ratios
Market Cap?1.9B
Shares Out?110.5M
Float?83.3M
Float %?75.9%
P/E Ratio?N/A
P/B Ratio?6.13
EPS?-$1.31
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?14.27Strong
Quick Ratio?14.27Strong
Cash Ratio?9.99Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?6.13FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-10.8CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-47.4%WEAK▾
ROA?-43.5%WEAK▾
Cash Flow & Enterprise
FCF?$-123481000
Enterprise Value?$1.6B
Related Companies
Loading...
News
Profile
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
Address
55 CAMBRIDGE PARKWAY
CAMBRIDGE, MA 02142
Phone: 617-682-0917
CAMBRIDGE, MA 02142
Phone: 617-682-0917